Hyoscine Butylbromide Ria Generics (Hyoscine Butylbromide)

Hyoscine Butylbromide acts on smooth‑muscle disorders of the gastrointestinal tract, providing relief from spasm‑related pain.

• Abdominal cramping: reduces intensity and frequency of painful cramps.
• Irritable bowel syndrome: eases bowel‑spasm symptoms and associated discomfort.
• Biliary colic: alleviates spasmodic pain caused by gall‑stone obstruction.
• Gastrointestinal spasm: relaxes smooth muscle to improve motility and reduce discomfort.

• Hyoscine Butylbromide competitively antagonises muscarinic acetylcholine receptors (M1–M5) on gastrointestinal smooth muscle. By blocking cholinergic stimulation, it prevents calcium influx that drives contraction, leading to relaxation of the smooth muscle layers and reduction of spasm without significant systemic anticholinergic effects due to its poor absorption.

Hyoscine Butylbromide may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Dry mouth: reduced salivary secretion causing throat discomfort.
• Blurred vision: transient difficulty focusing, especially in low light.
• Constipation: slowed intestinal transit leading to harder stools.
• Dizziness: light‑headed sensation, often postural.

Serious or Rare Side Effects

• Allergic reactions: rash, pruritus, or angioedema requiring medical attention.
• Severe hypotension: sudden drop in blood pressure with fainting risk.
• Confusion or hallucinations: central anticholinergic effects, particularly in the elderly.
• Paralytic ileus: marked cessation of intestinal motility demanding urgent care.

Before prescribing Hyoscine Butylbromide, clinicians should evaluate patient history and potential risk factors.

• Contraindications: avoid in patients with known hypersensitivity to hyoscine derivatives.
• Glaucoma: use with caution as anticholinergic activity may increase intra‑ocular pressure.
• Elderly patients: monitor closely for anticholinergic burden and cognitive effects.
• Concomitant anticholinergics: assess for additive side‑effects.
• Pregnancy and lactation: consider risk‑benefit ratio; limited data available.
• Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Hyoscine Butylbromide can interact with other medicines, altering its safety profile.

Major Interactions (Avoid)

• Other anticholinergic agents (e.g., antihistamines, tricyclic antidepressants): additive anticholinergic load.
• Anticholinergic anesthetics (e.g., atropine): may potentiate muscarinic blockade.
• Antiparkinson drugs with anticholinergic properties: increased risk of confusion.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may mask tachycardia caused by anticholinergic effects.
• Opioids: combined use can exacerbate constipation.
• Diuretics: may intensify dry‑mouth symptoms.
• Antiemetics with anticholinergic activity (e.g., scopolamine): monitor for excessive dryness and blurred vision.